June 23, 2023 Comments Off on New patent for Viiv Hlthcare drug TRIUMEQ Posted in: Patent Added Annual Drug Patent Expirations for TRIUMEQ Triumeq is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from one supplier. There are two patents…
The post New patent for Viiv Hlthcare drug TRIUMEQ appeared first on DrugPaten…
June 23, 2023 Comments Off on New patent expiration for Azurity drug NYMALIZE Posted in: Uncategorized
Annual Drug Patent Expirations for NYMALIZE Nymalize is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent expiration for Azurity drug NYMALIZE appeared firs…
